EG435601 Activators
Pdzd7, a PDZ domain-containing protein, plays a crucial role in auditory receptor cell stereocilium organization, detection of mechanical stimuli in sound perception, and establishment of protein localization within stereocilia. Located in the stereocilia ankle link and stereocilium, it is part of the USH2 complex and stereocilia ankle link complex. Human orthologs of Pdzd7 are implicated in Usher syndrome type 2A, Usher syndrome type 2C, and autosomal recessive nonsyndromic deafness 57. Activation of Pdzd7 involves a complex interplay of various chemicals that either directly up-regulate the protein or indirectly influence pathways related to auditory receptor cell stereocilium organization. Forskolin, through its activation of adenylate cyclase and subsequent cAMP increase, may stimulate Pdzd7 by activating PKA-dependent pathways. Retinoic acid, a vitamin A derivative, may modulate gene expression, indirectly affecting Pdzd7 and pathways associated with stereocilia organization. Lithium chloride, a GSK3β inhibitor, could stimulate Pdzd7 by inhibiting GSK3β, influencing upstream pathways.
Inhibition of ROCK by Y-27632, HDAC by Valproic acid, and TGF-β signaling by SB-431542 may also contribute to Pdzd7 activation. Aminoglycoside antibiotics could indirectly affect Pdzd7 by impacting stereocilia development and protein localization. Compounds like Chloroquine, Curcumin, N-Acetylcysteine, Thapsigargin, and Cisplatin may influence Pdzd7 through various mechanisms, affecting pathways associated with stereocilia organization and protein localization. In summary, Pdzd7 activation is a multifaceted process involving the modulation of various signaling pathways and cellular processes crucial for auditory receptor cell stereocilium organization. The intricate network of chemicals highlights the complexity of Pdzd7's role in auditory function and provides potential avenues for further exploration in understanding and potentially manipulating auditory processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a derivative of vitamin A, may indirectly activate Pdzd7 by modulating gene expression. It could influence pathways related to auditory receptor cell stereocilium organization and sensory perception of sound. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride, a GSK3β inhibitor, may stimulate Pdzd7 by inhibiting GSK3β, potentially affecting pathways upstream of auditory receptor cell stereocilium organization. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a ROCK inhibitor, may up-regulate Pdzd7 by inhibiting ROCK, potentially influencing pathways associated with auditory receptor cell stereocilium organization. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, an HDAC inhibitor, may stimulate Pdzd7 through epigenetic regulation. It could influence pathways related to auditory receptor cell stereocilium organization and sensory perception of sound. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, a lysosomotropic agent, may up-regulate Pdzd7 by modulating lysosomal function. It could potentially affect pathways involved in protein localization and stereocilia organization. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural compound, may stimulate Pdzd7 by influencing various signaling pathways. Its impact on pathways related to auditory receptor cell stereocilium organization could contribute to Pdzd7 activation. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-Acetyl-L-cysteine, an antioxidant, may indirectly activate Pdzd7 by reducing oxidative stress. Its impact on cellular redox status could influence pathways associated with auditory receptor cell stereocilium organization. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542, a TGF-β receptor inhibitor, may up-regulate Pdzd7 by inhibiting TGF-β signaling. It could potentially influence pathways involved in auditory receptor cell stereocilium organization. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, a SERCA inhibitor, may stimulate Pdzd7 by affecting calcium signaling. Its impact on pathways related to auditory receptor cell stereocilium organization could contribute to Pdzd7 activation. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, an anticancer drug, may indirectly influence Pdzd7 by affecting stereocilia development. Although specific CAS numbers may vary, cisplatin could impact auditory receptor cell stereocilium organization. | ||||||